24 - 27 January 2022

Dubai World Trade Centre

5 January - 28 February

Public-Private Partnerships in Global Health: bringing the best of both worlds to improve testing


GC Labs


Tuesday 25th January | 12:00 - 15:00


Global Health has seen big paradigm changes in the last two decades. Once Government centric, public health has evolved, giving space to International Organizations and NGOs to become active strategic and operational actors. And political decision makers now turn to Private Sector involvement in developing better and more effective products, health infrastructure and services.

The Private Sector is now a fundamental player, bringing innovative solutions that, when accessible to all the population, can contribute to improve the quality of life of the population. In this dialectic evolving process, private for-profit organizations have realized the importance of public health goals for their corporate objectives, and accepted a broader view of social responsibility as part of the corporate mandate.

Public-Private partnerships can be effective vehicles for addressing complex public health problems. In the national and international arenas, these alliances are continuously formed to tackle some of the most pressing health challenges of our era, that call for a multi-sectorial approach and collaboration between all actors.

Learning objectives

  • Learn more about how the private sector is now a fundamental player can contribute to improve the quality of life of the population
  • How public-private partnerships can be effective vehicles for addressing complex public health problems


Lelio Marmora
CEO, The Management Lab Ltd

Lelio Marmora is an international development leader with more than 30 years of experience overseeing public and private large-scale investments in more than 100 countries. Mr. Marmora serves companies and international organizations around the world at the board and executive-committee levels. He is the CEO of The Management Lab, an advisory firm based in Geneva, Switzerland, specialized in large-scale investments for clients that include life sciences multinational companies, international organizations and Governments. He is also a board member at the London-based MTV Foundation, a founding member of the Think Tank Santé Mondiale 2030 in Paris, France, and a member of a number of expert advisory groups on international development, biotech/medtech and innovation issues.

Michel Kazatchkine
Senior Fellow, Graduate Institute for International Affairs and Development, Geneva

Professor Michel Kazatchkine has over 35 years of experience in global health as a leading physician, researcher, administrator, advocate, policymaker, and diplomat. Professor Kazatchkine has played key roles in various organizations, serving as Director of the national Agency for Research on AIDS in France and French ambassador on HIV/AIDS and communicable diseases. He is also Senior Fellow with the Global Health Centre of the Graduate Institute for International and Development Studies in Geneva, and a member of the Global Commission on Drug Policy. Professor Kazatchkine holds Honorary Degrees from Imperial College, London, the Free University of Brussels, the Catholic University of Louvain and the University of Geneva. He is an Officer of the Légion d’Honneur in France and the recipient of several other national Orders and national/ international awards.

Eskild Petersen
Professor, Institute for Clinical Medicine, Aarhus University, Denmark

Professor Eskild Petersen is a Professor Emeritus of infectious diseases, Institute for Clinical Medicine, Faculty of Health Science, Aarhus University, Denmark. He chairs the European Society for Infectious Diseases Emerging Infections Task Force, Basel, Switzerland. Professor Petersen is internationally renowned for his extensive contributions to global health, tuberculosis control, multi-drug resistant infections, travel medicine and emerging infections.
Professor Petersen graduated in 1978 from Medical School, University of Aarhus, Denmark; 1980 Diploma in Tropical Medicine and Hygiene, University of Liverpool; 1985 Specialist Degree in Infectious Diseases; 1988 Specialist Degree in Tropical Medicine; 2002 Master of Business Administration, Copenhagen Business School; 2005 DMSc., Karolinska Institute, Stockholm, Sweden. 

Dr. Amina Khalfan Said Al- Jardani
Laboratory Director, Central Public Health Laboratories, Ministry of Health, Oman

Medical microbiology and infectious disease consultant. Currently, the Director of Central Public Health Laboratories (CPHL), leading the work of the national reference laboratories. Dr. Amina Khalfan Said Al- Jardani received her MD degree from Sultan Qaboos University in Oman and obtained the American Board of Internal Medicine in 2003 after completing an internal medicine residency program from McGill University in Canada. She is a member of several national committees including the national laboratory medicine committee, the vaccine committee, national polio and measles expert committee and the national infection prevention and control sub-committee. Qualifications: MD, FRCPC (Internal Medicine), ABIM (Internal Medicine), FRCPC (Medical Microbiology), FRCPC (Infectious Diseases)

Dr. Eun-Hee Lee
President, GC Labs

Dr. Eun-Hee Lee, MD/PhD/MBA, graduated from Ewha Womans University School of Medicine in 1986, and obtained a PhD in laboratory medicine from the same university, South Korea. Her residency was at Hallym University hospital, South Korea in laboratory medicine. She received her MBA from Yonsei University Business School in 2005. She completed Global Health Delivery program by Harvard University in 2019 and program of Artificial Intelligence, implications for business strategy by MIT Sloan School of Management in 2020. She joined GC Labs in 1990 and has been working as the president since April 2007. Dr. Lee is a clinical pathologist with over 30 years of experience in laboratory medicine.

Dr. Unyeong Go
Director, Center for Infectious Disease, GC Labs

Unyeong GO, MD is the Director of Center for Infectious Diseases, GC Labs since January 2021 and directs the operational research and education program on infectious diseases including COVID-19, HIV/AIDS, tuberculosis. Dr GO is an infectious disease epidemiologist, completed medical school at Han-Yang University and trained in preventive medicine at Seoul National University, Korea. In 1997, she joined Korea Disease Control and Prevention Agency, served in control of infectious diseases. She seconded to WHO, HQ in Division of Pandemic and Epidemic Disease (2010-2012). She served as a national TB program manager in Korea (2013-2018).